In this report, we looked at whether repeat prostate-specific antigen (PSA) measurements, or PSA kinetics, improve prediction of biopsy outcomes in men using active surveillance to manage localized prostate cancer. We found that in a large multicenter active surveillance cohort, PSA kinetics improves the prediction of surveillance biopsy outcome.
CITATION STYLE
Cooperberg, M. R., Brooks, J. D., Faino, A. V., Newcomb, L. F., Kearns, J. T., Carroll, P. R., … Zheng, Y. (2018). Refined Analysis of Prostate-specific Antigen Kinetics to Predict Prostate Cancer Active Surveillance Outcomes. European Urology, 74(2), 211–217. https://doi.org/10.1016/j.eururo.2018.01.017
Mendeley helps you to discover research relevant for your work.